For each calendar year, we calculated rates describing the overlap between semaglutide or tirzepatide prescriptions and PCOS diagnoses: Among female patients who received a semaglutide or tirzepatide prescription in a given year, we calculated the proportion who had a recorded PCOS diagnosis in or before that year
Clinical trial data from the SUSTAIN program and STEP trials documented dizziness in approximately 2-5% of semaglutide users across dose levels, typically resolving within the first 2-4 weeks of treatment
Regarding mammals, their existence was demonstrated in humans, monkeys, rabbits, rats, mice, guinea pigs, pigs, cattle, sheep, goats, and horses [104]
What is Weight Watchers, and how does it work